Agenus
Manufacturing · Massachusetts, United States · 51-200 Employees
View Company Info for Free
Overview
Headquarters
3 Forbes Rd, Lexington, Massachusetts, 0...Phone Number
(781) 674-4400Website
www.agenusbio.comRevenue
$123.9 MillionStock Symbol
AGENIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
3
4
1
1
1
1
About Agenus
Agenus researches, develops, and manufactures immuno-oncology products such as, checkpoint antibodies, cell therapies, vaccines and adjuvants. The company's proprietary discovery engine Retrocyte Display is used to generate fully human therapeutic antibody drug candidates. The headquarters is located in Lexington, Massachusetts.Explore more
Agenus Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Agenus your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Click to see if Agenus had a recent Job posting/layoffs
Congratulate Masked Content for being promoted to Masked Content at Agenus
Earning: See what the market has to say on Agenus recently announced quarterly report
Check out if Agenus is spiking on competitors!
Website visits: Recent activity has been detected on your website
Product Launch: Get notified when Agenus launches new products
Check if Agenus has recently received funding, and reach out quickly before it becomes old news!
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Funding: Get notified immidiatlly once Agenus has new funding data
Agenus, which may be a good buyer, showed buying intent in Masked Content Topic
Recommended Actions
Find VP level buyers at Agenus
Find more new buyers
Compare Similar Companies to Agenus
Compare insights from companies similar to Agenus, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Agenus is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Agenus is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Agenus.
Agenus financials insights
Gather financial insights about Agenus, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2009
Share Placement
$10M
2013
Debt
$5M
2015
Debt
$21.1M
Debt
$100M
2017
Share Placement
$60M
2018
Debt
$230M
2020
Debt
$1M
Private Equity
$35M
Agenus Tech Stack
A closer look at the technologies used by Agenus
See more technologies
Most Recent Scoops
Person-Based
Medical Research, Pharmaceuticals
Person-Based
Medical Research, Pharmaceuticals
Project
Laboratory Operations, Medical Research, Clinical Operations
Project
Laboratory Operations, Medical Research, Clinical Operations
Person-Based
Lawsuits, Legal Affairs
Agenus News & Media
Agenus and Zydus complete $141m BOT+BAL immunotherapy collaboration deal
Agenus has provided Zydus with exclusive rights to develop and commercialise BOT/BAL in India and Sri Lanka.Zydus Lifesciences Limited completes the acquisition of Agenus Inc.'s biologics manufacturing facilities, launches Zylidac Bio LLC in the U.S.
AHMEDABAD, India and PENNINGTON, N.J., Jan. 15, 2026 /PRNewswire/ -- Zydus Lifesciences Limited (including its subsidiaries/affiliates, hereafter referred to as "Zydus") is an innovation-led life-sciences company with an international presence, today announced the successful closure of...Agenus Inc. (AGEN) Shareholder/Analyst Call Transcript
Agenus Inc. (AGEN) Shareholder/Analyst Call December 3, 2025 4:00 PM ESTCompany ParticipantsStefanie Perna-Nacar - Chief Communications & Government...Agenus (AGEN) Misses Q3 Earnings and Revenue Estimates
Agenus (AGEN) delivered earnings and revenue surprises of -26.24% and -71.95%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?
Read more news
Top Manufacturing Companies
See more top companies
Frequently Asked Questions Regarding Agenus
Sign Up For FreeTo access detailed company insights
Agenus researches, develops, and manufactures immuno-oncology products such as, checkpoint antibodies, cell therapies, vaccines and adjuvants. The company's proprietary discovery engine Retrocyte Display is used to generate fully human therapeutic antibody drug candidates. The headquarters is located in Lexington, Massachusetts.... Read More
